We are live on ! Find out more
FTXH icon

First Trust Nasdaq Pharmaceuticals ETF
FTXH

18 hedge funds and large institutions have $7.06M invested in First Trust Nasdaq Pharmaceuticals ETF in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

13% more funds holding

Funds holding: 16 → 18 (+2)

5.63% less ownership

Funds ownership: 45.74% → 40.11% (-5.6%)

14% less capital invested

Capital invested by funds: $8.23M → $7.06M (-$1.17M)

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FTUS
Flow Traders U.S.
New York
+$633K
2
IAN
Integrated Advisors Network
Texas
+$55.2K
3
Morgan Stanley
Morgan Stanley
New York
+$15.8K
4
Wells Fargo
Wells Fargo
California
+$53

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$743K
2
Citadel Advisors
Citadel Advisors
Florida
-$591K
3
JAWM
J. Arnold Wealth Management
Ohio
-$511K
4
LJAC
L.J. Altfest & Co
New York
-$295K
5
LPL Financial
LPL Financial
California
-$64.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Credit Suisse
Switzerland
$1.68M -$1.63K -62 -0.1%
LPL Financial
2
LPL Financial
California
$1.62M -$64.6K -2,461 -4%
IAN
3
Integrated Advisors Network
Texas
$830K +$55.2K +2,103 +7%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$755K -$743K -28,296 -50%
LJAC
5
L.J. Altfest & Co
New York
$665K -$295K -11,233 -31%
FTUS
6
Flow Traders U.S.
New York
$652K +$633K +24,090 New
Goldman Sachs
7
Goldman Sachs
New York
$542K – – –
Osaic Holdings
8
Osaic Holdings
Arizona
$207K -$27.9K -1,061 -12%
HI
9
Harbour Investments
Wisconsin
$23K – – –
JAWM
10
J. Arnold Wealth Management
Ohio
$16K -$511K -19,451 -97%
ADL
11
Asset Dedication LLC
California
$16K – – –
Morgan Stanley
12
Morgan Stanley
New York
$16K +$15.8K +600 New
SPIA
13
Steward Partners Investment Advisory
New York
$11K – – –
UBS Group
14
UBS Group
Switzerland
$10K -$15.6K -594 -62%
IA
15
IFP Advisors
Florida
$9K – – –
APA
16
American Portfolios Advisors
New York
$2.71K – – –
SC
17
Solstein Capital
California
$1K – – –
Citadel Advisors
18
Citadel Advisors
Florida
– -$591K -23,129 Closed
Wells Fargo
19
Wells Fargo
California
– +$53 +2 New

FTXH Hedge Fund Activity: Q4 2021 in Review

18 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) for Q4 2021, worth a combined $7.06M — down 14% from $8.23M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new FTXH positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 7 trimmed.

The largest buyer was Flow Traders U.S., opening a new position worth an estimated $633K. The largest seller was Susquehanna International Group, cutting an estimated $743K.

  • 18 institutional investors held First Trust Nasdaq Pharmaceuticals ETF (FTXH) as of Q4 2021, up from 16 in Q3 2021.
  • Funds reported $7.06M of First Trust Nasdaq Pharmaceuticals ETF stock for Q4 2021, down 14% quarter-over-quarter.
  • 3 funds opened new First Trust Nasdaq Pharmaceuticals ETF positions in Q4 2021 and 1 closed out, a net change of +2 holders.
  • The largest First Trust Nasdaq Pharmaceuticals ETF buyer in Q4 2021 was Flow Traders U.S., an estimated $633K added.
  • The largest First Trust Nasdaq Pharmaceuticals ETF seller in Q4 2021 was Susquehanna International Group, an estimated $743K sold.

Based on aggregated 13F filings for Q4 2021.